Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net revenues $ 3,130 $ 5,637 $ 7,983 $ 16,462
Cost of revenues 898 2,418 2,757 7,757
Gross profit 2,232 3,219 5,226 8,705
Operating expenses:        
Sales and marketing 383 705 1,265 2,094
General and administrative 4,276 3,754 11,981 11,699
Research and development 572 1,052 1,811 3,438
Legal settlement 4,500 0 4,500 0
Total operating expenses 9,731 5,511 19,557 17,231
Operating loss (7,499) (2,292) (14,331) (8,526)
Other expense:        
Interest expense (1,362) (145) (1,923) (484)
Loss on extinguishment of debt (950) 0 (1,031) 0
Gain on change in fair value of warrants 1,244 0 1,244 0
Other (expense) income 0 11 0 28
Total other expense (1,068) (134) (1,710) (456)
Loss before taxes (8,567) (2,426) (16,041) (8,982)
Income tax expense 0 0 0 (5)
Net loss (8,567) (2,426) (16,041) (8,987)
Other comprehensive loss:        
Cumulative translation adjustment 47 (33) (28) (36)
Comprehensive loss $ (8,520) $ (2,459) $ (16,069) $ (9,023)
Net loss per common share, basic and diluted (in dollars per share) $ (0.19) $ (0.06) $ (0.38) $ (0.25)
Weighted-average common shares used to compute net loss per share, basic and diluted (in shares) 44,304 39,027 42,089 36,034